Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of Nav1.7 Inhibitors through the Screening of Marine Natural Product Extracts. | J Nat Prod | 2025 | 41124213 | PubTator, text mining | PubMed |
| Co-cultured sensory neuron classification using extracellular electrophysiology and machine learning approaches for enhancing analgesic screening. | J Neural Eng | 2025 | 41038255 | PubTator, text mining | PubMed |
| Association of compression pressure and SCN8A and SCN9A gene polymorphisms with the recurrence of balloon compression-treated trigeminal neuralgia. | Neurosurg Rev | 2025 | 41037137 | PubTator, text mining | PubMed |
| Possible Anti-Pain Vaccines: A Narrative Review of Emerging Strategies and Clinical Prospects. | Vaccines (Basel) | 2025 | 41012116 | PubTator, text mining | PubMed |
| Modification of Closed-State Inactivation in Voltage-Gated Sodium Channel Nav1.7 by Two Novel Arachnid Toxins. | Toxins (Basel) | 2025 | 41003497 | PubTator, text mining | PubMed |
| Patient Subgroups and Predictors of Improvement in Chronic Neuropathic Pain: A Trajectory-Based Analysis. | Eur J Pain | 2025 | 40990399 | PubTator, text mining | PubMed |
| Dynamic current-clamp unveiling the indispensable interplay between Nav1.7 and Nav1.8 for shaping action potential trajectory and retaining neuroexcitation of visceral sensory neurons. | Neurosci Lett | 2025 | 40983134 | PubTator, text mining | PubMed |
Three-dimensional Quantitative Structure-activity Relationship, Molecular Docking and Absorption, Distribution, Metabolism, and Excretion Studies of Lidocaine Analogs Pertaining to Voltage-gated Sodium Channel Nav1.7 Inhibition for the Management of Neuropathic Pain. | Int J Appl Basic Med Res | 2025 | 40937022 | PubTator, text mining | PubMed |
| Six at Sixty. 'No gain, no pain': medical genetics taking Nav1.7 from target to pharmacy. | J Med Genet | 2025 | 40935605 | PubTator, text mining | PubMed |
| Robust and accurate Bayesian inference of genome-wide genealogies for hundreds of genomes. | Nat Genet | 2025 | 40921789 | PubTator, text mining | PubMed |
| Design, synthesis, structure-activity relationship (SAR) and analgesic effect studies of novel arylsulfonamides as selective Nav1.7 inhibitors. | Eur J Med Chem | 2025 | 40882438 | PubTator, text mining | PubMed |
| Enhancing Chemical Stability and Bioavailability of Aneratrigine Capsules via Dry Granulation: Addressing Stability Challenges in Sodium Bicarbonate-Containing Formulations for Clinical Development. | Pharmaceutics | 2025 | 40871068 | PubTator, text mining | PubMed |
| Pain management beyond opioids: a β-arrestin2-biased allosteric GPCR modulator opens new avenues for drug development. | Signal Transduct Target Ther | 2025 | 40858534 | PubTator, text mining | PubMed |
| A deep learning model to predict glioma recurrence using integrated genomic and clinical data. | Commun Med (Lond) | 2025 | 40830273 | PubTator, text mining | PubMed |
| Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy. | J Clin Invest | 2025 | 40828619 | PubTator, text mining | PubMed |
| New perspectives for optimizing fever and pain management in pediatrics: evidence supporting therapeutic awareness in clinical practice. | Ital J Pediatr | 2025 | 40817220 | PubTator, text mining | PubMed |
| Decoding Pain: Next-Generation In Vitro Systems for Mechanistic Insights and Drug Discovery. | FASEB J | 2025 | 40814286 | PubTator, text mining | PubMed |
| Multidimensional pan cancer analysis of the sodium induced cell death gene TRPM4. | Sci Rep | 2025 | 40804073 | PubTator, text mining | PubMed |
| Targeting Nav1.8 with the nonopioid antagonist suzetrigine for analgesia: cause for optimism? | Br J Anaesth | 2025 | 40796490 | PubTator, text mining | PubMed |
| Towards development of Nav1.7 channel modulators for pain treatment: A comparison of mexiletine effect in two cell models by automated patch clamp. | Biomed Pharmacother | 2025 | 40795473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers?page=7